Search hospitals > North Carolina > Greensboro
Cone Health Cancer Center
Claim this profileGreensboro, North Carolina 27403
Global Leader in Breast Cancer
Global Leader in Parotid Gland Cancer
Conducts research for Lung Cancer
Conducts research for Breast cancer
Conducts research for Cervical Adenocarcinoma
171 reported clinical trials
3 medical researchers
Summary
Cone Health Cancer Center is a medical facility located in Greensboro, North Carolina. This center is recognized for care of Breast Cancer, Parotid Gland Cancer, Lung Cancer, Breast cancer, Cervical Adenocarcinoma and other specialties. Cone Health Cancer Center is involved with conducting 171 clinical trials across 204 conditions. There are 3 research doctors associated with this hospital, such as Vinay K. Gudena, Sarah E. Squire, and Ni Gorsuch.Area of expertise
1Breast Cancer
Global LeaderER positive
HER2 negative
PR positive
2Parotid Gland Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Vinay K. GudenaCone Health Cancer Center1 year of reported clinical research
Studies Breast Cancer
Studies Lung Cancer
32 reported clinical trials
67 drugs studied
Sarah E. SquireCone Health Cancer Center6 years of reported clinical research
Studies Metastasis
Studies Brain Tumor
1 reported clinical trial
3 drugs studied
Ni GorsuchCone Health Cancer Center5 years of reported clinical research
Studies Fallopian Tube Carcinosarcoma
Studies Mullerian Tumor
1 reported clinical trial
3 drugs studied
Clinical Trials running at Cone Health Cancer Center
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Breast cancer
Parotid Gland Cancer
Squamous Cell Carcinoma
Esophageal cancer
Esophageal Cancer
Esophageal Adenocarcinoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Cognitive Training
for Breast Cancer Survivors
This Phase III trial will examine the efficacy of computerized cognitive training methods on perceived cognitive impairment in breast cancer survivors.
Recruiting1 award N/A5 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Cone Health Cancer Center?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.